\-\ Texto\\:\\ \ \(0\)\
\-\ a\\ well\\-developed\\ in\\ no\\ acute\\ distress\\.\\ \\ \ \(0\)\
\-\ there\\ is\\ no\\ adenopathy\\ noted\\ in\\ the\\ cervical\\,\\ supraclavicular\\,\\ or\\ axillary\\ areas\\.\\ \\ \ \(0\)\
\-\ lungs\\ are\\ clear\\.\\ \\ heart\\:\\ \\ regular\\ rate\\ and\\ rhythm\\.\\ \\ there\\ are\\ no\\ masses\\,\\ tenderness\\,\\ or\\ discharge\\ noted\\ on\\ the\\ reconstructed\\ left\\ breast\\ nor\\ in\\ the\\ right\\ breast\\.\\ abdomen\\:\\ \\ normoactive\\ bowel\\ sounds\\.\\ \\ soft\\,\\ nontender\\,\\ nondistended\\ without\\ any\\ hepatosplenomegaly\\.\\ \\ there\\ is\\ no\\ inguinal\\ adenopathy\\.\\ \\ extremities\\:\\ \\ without\\ clubbing\\,\\ cyanosis\\,\\ or\\ edema\\.\\ \\ neuro\\:\\ \\ cranial\\ nerves\\ ii\\ through\\ xii\\ are\\ intact\\,\\ otherwise\\,\\ is\\ nonfocal\\.\ \(0\)\
\-\ the\\ patient\\ will\\ be\\ followed\\ up\\ by\\ interventional\\ radiology\\ for\\ splenic\\ artery\\ embolization\\ because\\ of\\ the\\ risk\\ of\\ rupture\\ which\\ carries\\ a\\ high\\ mortality\\ rate\\.\ \(0\)\
\-\ contrast\\ enhanced\\ biphasic\\ ct\\ scan\\ of\\ the\\ abdomen\\ shows\\ a\\ well\\ circumscribed\\ lesion\\ in\\ the\\ head\\/body\\ of\\ the\\ pancreas\\ that\\ is\\ highly\\ attenuated\\ in\\ the\\ arterial\\ phase\\.\\ the\\ lesion\\ measures\\ 3\\.8\\ x\\ 3\\.5\\ cm\\ which\\ has\\ not\\ significantly\\ changed\\ in\\ size\\ when\\ compared\\ to\\ pet\\/ct\\ scans\\ dated\\ 10\\/29\\/2010\\ and\\ 6\\/23\\/2010\\,\\ done\\ at\\ an\\ outside\\ facility\\.\\ there\\ are\\ \\ feeding\\ and\\ draining\\ vessel\\ in\\ close\\ proximity\\ posteriorly\\.\\ this\\ enhancing\\ lesion\\ represents\\ a\\ splenic\\ artery\\ aneurysm\\ in\\ the\\ middle\\ region\\ of\\ the\\ splenic\\ artery\\ located\\ in\\ the\\ body\\ of\\ the\\ pancreas\\.\\ \\ pre\\-contrast\\ study\\ reveals\\ no\\ significant\\ calcification\\ in\\ the\\ vessel\\ walls\\.\ \(0\)\
\-\ splenic\\ artery\\ aneurysm\ \(6\)\
\-\ \\â\\€\\¢\\ splenic\\ artery\\ aneurysm\ \(1\)\
\-\ \\â\\€\\¢\\ pancreatic\\ pseudocyst\ \(1\)\
\-\ \\â\\€\\¢\\ pseudoaneurysm\ \(1\)\
\-\ this\\ 63\\ y\\.o\\.\\ woman\\ originally\\ presented\\ with\\ breast\\ cancer\\ \\(ductal\\ carcinoma\\-in\\-situ\\)\\ 3\\ yrs\\ ago\\.\ \(0\)\
\-\ this\\ finding\\ of\\ splenic\\ artery\\ aneurysm\\ was\\ an\\ incidental\\ finding\\ during\\ a\\ workup\\ for\\ this\\ patient\\'s\\ metastatic\\ breast\\ cancer\\.\\ the\\ patient\\ was\\ asymptomatic\\ and\\ did\\ not\\ report\\ abdominal\\ pain\\.\\ in\\ addition\\,\\ the\\ mass\\ was\\ not\\ palpated\\/auscultated\\ during\\ the\\ physical\\ exam\\.\\ this\\ is\\ not\\ an\\ uncommon\\ presentation\\ for\\ a\\ splenic\\ artery\\ aneurysm\\ as\\ 90\\%\\ of\\ patients\\ are\\ diagnosed\\ incidentally\\.\ \(0\)\
\-\ regarding\\ her\\ breast\\ cancer\\,\\ 3\\ years\\ ago\\ she\\ had\\ a\\ biopsy\\,\\ which\\ revealed\\ a\\ ductal\\ carcinoma\\ with\\ microinvasive\\ disease\\.\\ \\ she\\ had\\ done\\ well\\ postoperatively\\,\\ until\\ this\\ summer\\ when\\ she\\ palpated\\ a\\ left\\ supraclavicular\\ node\\.\\ \\ she\\ had\\ a\\ biopsy\\ via\\ fna\\,\\ which\\ revealed\\ a\\ metastatic\\ adenocarcinoma\\.\\ \\ her\\ most\\ recent\\ petct\\ from\\ one\\ month\\ ago\\ revealed\\ progression\\ as\\ compared\\ to\\ a\\ previous\\ exam\\ five\\ months\\ earlier\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ splenic\\:\\ 0\\.08156434703672671\ \(0\)\
\-\ artery\\:\\ 0\\.04486576812281459\ \(0\)\
\-\ aneurysm\\:\\ 0\\.04253701656225822\ \(0\)\
\-\ breast\\:\\ 0\\.0397047599978659\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.026499598803411004\ \(0\)\
\-\ she\\:\\ 0\\.024169129888707026\ \(0\)\
\-\ ago\\:\\ 0\\.024035734162195833\ \(0\)\
\-\ head\\/body\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ 10\\/29\\/2010\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ 6\\/23\\/2010\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ carcinoma\\-in\\-situ\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ palpated\\/auscultated\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ microinvasive\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ petct\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ pancreas\\:\\ 0\\.022029557518771694\ \(0\)\
\-\ cancer\\:\\ 0\\.02122794910099319\ \(0\)\
\-\ revealed\\:\\ 0\\.020723984054403725\ \(0\)\
\-\ vessel\\:\\ 0\\.020506731967774548\ \(0\)\
\-\ ductal\\:\\ 0\\.02029232584979573\ \(0\)\
\-\ summer\\:\\ 0\\.01943805071863574\ \(0\)\
\-\ adenopathy\\:\\ 0\\.019168176976676284\ \(0\)\
\-\ biphasic\\:\\ 0\\.018713410737648886\ \(0\)\
\-\ dated\\:\\ 0\\.018713410737648886\ \(0\)\
\-\ compared\\:\\ 0\\.018221770240305656\ \(0\)\
\-\ done\\:\\ 0\\.017846442646865246\ \(0\)\
\-\ xii\\:\\ 0\\.017303799181136486\ \(0\)\
\-\ rate\\:\\ 0\\.01677945335252314\ \(0\)\
\-\ nonfocal\\:\\ 0\\.01667076535675133\ \(0\)\
\-\ 3\\.8\\:\\ 0\\.01640537362965353\ \(0\)\
\-\ postoperatively\\:\\ 0\\.016165297609995282\ \(0\)\
\-\ which\\:\\ 0\\.016071985765667998\ \(0\)\
\-\ attenuated\\:\\ 0\\.015744506464748013\ \(0\)\
\-\ pre\\-contrast\\:\\ 0\\.015744506464748013\ \(0\)\
\-\ reconstructed\\:\\ 0\\.015557836509700855\ \(0\)\
\-\ carries\\:\\ 0\\.015384050939204755\ \(0\)\
\-\ pet\\/ct\\:\\ 0\\.015384050939204755\ \(0\)\
\-\ biopsy\\:\\ 0\\.015273013811772092\ \(0\)\
\-\ well\\-developed\\:\\ 0\\.015221485394777624\ \(0\)\
\-\ normoactive\\:\\ 0\\.015068778538816831\ \(0\)\
\-\ are\\:\\ 0\\.014670955573420677\ \(0\)\
\-\ proximity\\:\\ 0\\.014659410958217902\ \(0\)\
\-\ fna\\:\\ 0\\.014536513819252077\ \(0\)\
\-\ this\\:\\ 0\\.014526003223891179\ \(0\)\
\-\ hepatosplenomegaly\\:\\ 0\\.014200162704328846\ \(0\)\
\-\ nondistended\\:\\ 0\\.013998543793312382\ \(0\)\
\-\ had\\:\\ 0\\.013933373948922228\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.013903479994866925\ \(0\)\
\-\ finding\\:\\ 0\\.013874365264677488\ \(0\)\
\-\ changed\\:\\ 0\\.013638088267769124\ \(0\)\
\-\ yrs\\:\\ 0\\.013638088267769124\ \(0\)\
\-\ clubbing\\:\\ 0\\.0133228158673812\ \(0\)\
\-\ during\\:\\ 0\\.013173850125560745\ \(0\)\
\-\ lesion\\:\\ 0\\.013152810272043737\ \(0\)\
\-\ pseudoaneurysm\\:\\ 0\\.013042650539647638\ \(0\)\
\-\ palpated\\:\\ 0\\.013042650539647638\ \(0\)\
\-\ her\\:\\ 0\\.012944139337455595\ \(0\)\
\-\ interventional\\:\\ 0\\.01291344828678227\ \(0\)\
\-\ there\\:\\ 0\\.012813254976977216\ \(0\)\
\-\ abdomen\\:\\ 0\\.012752565556149604\ \(0\)\
\-\ cyanosis\\:\\ 0\\.01261676557732035\ \(0\)\
\-\ regarding\\:\\ 0\\.01261676557732035\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.012561403091882627\ \(0\)\
\-\ not\\:\\ 0\\.012441497952059802\ \(0\)\
\-\ when\\:\\ 0\\.012329124622750659\ \(0\)\
\-\ originally\\:\\ 0\\.012157517323431294\ \(0\)\
\-\ inguinal\\:\\ 0\\.0121112978305643\ \(0\)\
\-\ a\\:\\ 0\\.011987903329529509\ \(0\)\
\-\ 63\\:\\ 0\\.011934460906954101\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.01184141827402434\ \(0\)\
\-\ facility\\:\\ 0\\.011769228457367671\ \(0\)\
\-\ mortality\\:\\ 0\\.011729560051906363\ \(0\)\
\-\ axillary\\:\\ 0\\.011690506685317029\ \(0\)\
\-\ in\\:\\ 0\\.011675993782223688\ \(0\)\
\-\ nor\\:\\ 0\\.01150383673026987\ \(0\)\
\-\ draining\\:\\ 0\\.01143287734244444\ \(0\)\
\-\ \\:\\:\\ 0\\.011388159355069673\ \(0\)\
\-\ rhythm\\:\\ 0\\.01116748561534664\ \(0\)\
\-\ neuro\\:\\ 0\\.011105287598746209\ \(0\)\
\-\ workup\\:\\ 0\\.011074755204458187\ \(0\)\
\-\ nontender\\:\\ 0\\.011044588476380816\ \(0\)\
\-\ feeding\\:\\ 0\\.011044588476380816\ \(0\)\
\-\ significantly\\:\\ 0\\.011014778759385847\ \(0\)\
\-\ walls\\:\\ 0\\.010985317702047834\ \(0\)\
\-\ nerves\\:\\ 0\\.010927409595688392\ \(0\)\
\-\ \\,\\:\\ 0\\.010910229340747098\ \(0\)\
\-\ no\\:\\ 0\\.010836828094506323\ \(0\)\
\-\ metastatic\\:\\ 0\\.010836823192020605\ \(0\)\
\-\ five\\:\\ 0\\.010734613431652286\ \(0\)\
\-\ progression\\:\\ 0\\.010708237361457587\ \(0\)\
\-\ earlier\\:\\ 0\\.010630726886226469\ \(0\)\
\-\ pancreatic\\:\\ 0\\.010530955757523582\ \(0\)\
\-\ uncommon\\:\\ 0\\.010530955757523582\ \(0\)\
\-\ close\\:\\ 0\\.010506618450441122\ \(0\)\
\-\ discharge\\:\\ 0\\.01043498637154809\ \(0\)\
\-\ highly\\:\\ 0\\.010365335159128668\ \(0\)\
\-\ represents\\:\\ 0\\.010342539603662883\ \(0\)\
\-\ noted\\:\\ 0\\.010203633191196946\ \(0\)\
\-\ posteriorly\\:\\ 0\\.01016724163943317\ \(0\)\
\-\ 90\\:\\ 0\\.010146162924897865\ \(0\)\
\-\ without\\:\\ 0\\.010136086480393753\ \(0\)\
\-\ phase\\:\\ 0\\.01012525913947042\ \(0\)\
\-\ 3\\:\\ 0\\.010080481242854104\ \(0\)\
\-\ embolization\\:\\ 0\\.010023265785932042\ \(0\)\
\-\ scans\\:\\ 0\\.010023265785932042\ \(0\)\
\-\ regular\\:\\ 0\\.009925242067419009\ \(0\)\
\-\ node\\:\\ 0\\.00984948021543594\ \(0\)\
\-\ incidentally\\:\\ 0\\.009757874058834241\ \(0\)\
\-\ well\\:\\ 0\\.00973844308800328\ \(0\)\
\-\ report\\:\\ 0\\.009634976919868418\ \(0\)\
\-\ circumscribed\\:\\ 0\\.009567351604915801\ \(0\)\
\-\ exam\\:\\ 0\\.0094570979342546\ \(0\)\
\-\ until\\:\\ 0\\.009453207533852724\ \(0\)\
\-\ arterial\\:\\ 0\\.00942152294391101\ \(0\)\
\-\ cranial\\:\\ 0\\.009359324927310578\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.009298625804945186\ \(0\)\
\-\ ii\\:\\ 0\\.00928367684897588\ \(0\)\
\-\ via\\:\\ 0\\.009239355030612205\ \(0\)\
\-\ enhanced\\:\\ 0\\.00921023457116365\ \(0\)\
\-\ measures\\:\\ 0\\.00921023457116365\ \(0\)\
\-\ rupture\\:\\ 0\\.009138873093515725\ \(0\)\
\-\ addition\\:\\ 0\\.009124840234449087\ \(0\)\
\-\ radiology\\:\\ 0\\.009097006893928722\ \(0\)\
\-\ distress\\:\\ 0\\.009069477749011366\ \(0\)\
\-\ outside\\:\\ 0\\.009028740068291968\ \(0\)\
\-\ an\\:\\ 0\\.008929457412730955\ \(0\)\
\-\ located\\:\\ 0\\.008859448507351288\ \(0\)\
\-\ sounds\\:\\ 0\\.008585256051653348\ \(0\)\
\-\ extremities\\:\\ 0\\.008442535564082842\ \(0\)\
\-\ reveals\\:\\ 0\\.008421278967997539\ \(0\)\
\-\ previous\\:\\ 0\\.008358564732174549\ \(0\)\
\-\ lungs\\:\\ 0\\.00815060100246921\ \(0\)\
\-\ incidental\\:\\ 0\\.00815060100246921\ \(0\)\
\-\ clear\\:\\ 0\\.00795850532278752\ \(0\)\
\-\ diagnosed\\:\\ 0\\.007914849261448377\ \(0\)\
\-\ intact\\:\\ 0\\.007906208115108858\ \(0\)\
\-\ middle\\:\\ 0\\.007871936951240397\ \(0\)\
\-\ cervical\\:\\ 0\\.007821388933480172\ \(0\)\
\-\ calcification\\:\\ 0\\.007813062011227025\ \(0\)\
\-\ risk\\:\\ 0\\.007796490295614827\ \(0\)\
\-\ did\\:\\ 0\\.007771835367740362\ \(0\)\
\-\ otherwise\\:\\ 0\\.007731272628277947\ \(0\)\
\-\ or\\:\\ 0\\.007568181982093507\ \(0\)\
\-\ because\\:\\ 0\\.007530272837748231\ \(0\)\
\-\ heart\\:\\ 0\\.007478790047629154\ \(0\)\
\-\ was\\:\\ 0\\.0074680921074082125\ \(0\)\
\-\ presentation\\:\\ 0\\.007414107391665195\ \(0\)\
\-\ masses\\:\\ 0\\.007276051380342789\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.007276051380342789\ \(0\)\
\-\ areas\\:\\ 0\\.007242688088781025\ \(0\)\
\-\ recent\\:\\ 0\\.0072360681330977256\ \(0\)\
\-\ followed\\:\\ 0\\.007216312018586326\ \(0\)\
\-\ size\\:\\ 0\\.007216312018586326\ \(0\)\
\-\ x\\:\\ 0\\.0071009227590616555\ \(0\)\
\-\ study\\:\\ 0\\.007082194853551534\ \(0\)\
\-\ is\\:\\ 0\\.00708174783859856\ \(0\)\
\-\ body\\:\\ 0\\.0069905886969498345\ \(0\)\
\-\ any\\:\\ 0\\.006777921997663208\ \(0\)\
\-\ bowel\\:\\ 0\\.006750512677291585\ \(0\)\
\-\ enhancing\\:\\ 0\\.006750512677291585\ \(0\)\
\-\ will\\:\\ 0\\.006734209114305143\ \(0\)\
\-\ tenderness\\:\\ 0\\.006546378647057011\ \(0\)\
\-\ as\\:\\ 0\\.006511725470499385\ \(0\)\
\-\ patient\\:\\ 0\\.006472986883499153\ \(0\)\
\-\ month\\:\\ 0\\.006457467357180376\ \(0\)\
\-\ years\\:\\ 0\\.006320511680147311\ \(0\)\
\-\ the\\:\\ 0\\.006268229533161874\ \(0\)\
\-\ y\\.o\\:\\ 0\\.00621254265135189\ \(0\)\
\-\ through\\:\\ 0\\.006113241860002188\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0061005734761104945\ \(0\)\
\-\ edema\\:\\ 0\\.0060879684872324705\ \(0\)\
\-\ region\\:\\ 0\\.006079600068612878\ \(0\)\
\-\ scan\\:\\ 0\\.006025872696304732\ \(0\)\
\-\ shows\\:\\ 0\\.0059178178834480575\ \(0\)\
\-\ high\\:\\ 0\\.005890544234450417\ \(0\)\
\-\ months\\:\\ 0\\.005878945326675232\ \(0\)\
\-\ presented\\:\\ 0\\.005867399584439318\ \(0\)\
\-\ one\\:\\ 0\\.0058330765322686245\ \(0\)\
\-\ up\\:\\ 0\\.005788028088297792\ \(0\)\
\-\ significant\\:\\ 0\\.005788028088297792\ \(0\)\
\-\ cm\\:\\ 0\\.0057731892136448\ \(0\)\
\-\ patients\\:\\ 0\\.005570716874977395\ \(0\)\
\-\ for\\:\\ 0\\.0055096333650583\ \(0\)\
\-\ abdominal\\:\\ 0\\.005380149214413389\ \(0\)\
\-\ acute\\:\\ 0\\.005314557504046588\ \(0\)\
\-\ physical\\:\\ 0\\.005280869696678182\ \(0\)\
\-\ soft\\:\\ 0\\.005241629128447229\ \(0\)\
\-\ \\%\\:\\ 0\\.0050209597817279785\ \(0\)\
\-\ woman\\:\\ 0\\.004972047726672308\ \(0\)\
\-\ most\\:\\ 0\\.00496935803961732\ \(0\)\
\-\ contrast\\:\\ 0\\.0048180747778536655\ \(0\)\
\-\ left\\:\\ 0\\.004816651230594029\ \(0\)\
\-\ \\'s\\:\\ 0\\.004745709366163841\ \(0\)\
\-\ has\\:\\ 0\\.004042065416862161\ \(0\)\
\-\ that\\:\\ 0\\.0037178355883093787\ \(0\)\
\-\ by\\:\\ 0\\.0035840576907931352\ \(0\)\
\-\ disease\\:\\ 0\\.0035182305824073153\ \(0\)\
\-\ be\\:\\ 0\\.0033192864567857154\ \(0\)\
\-\ from\\:\\ 0\\.0031900143908166556\ \(0\)\
\-\ ct\\:\\ 0\\.0030108404367557755\ \(0\)\
\-\ mass\\:\\ 0\\.0029936045515052004\ \(0\)\
\-\ at\\:\\ 0\\.00291627998194366\ \(0\)\
\-\ pain\\:\\ 0\\.002628735938364571\ \(0\)\
\-\ of\\:\\ 0\\.0023476836432844016\ \(0\)\
\-\ \\.\\:\\ 0\\.0023249066461738114\ \(0\)\
\-\ right\\:\\ 0\\.002271112617406591\ \(0\)\
\-\ to\\:\\ 0\\.0021514766168412407\ \(0\)\
\-\ on\\:\\ 0\\.001823403053817199\ \(0\)\
\-\ \\(\\:\\ 0\\.0018195509477175328\ \(0\)\
\-\ and\\:\\ 0\\.0018136927529694554\ \(0\)\
\-\ \\)\\:\\ 0\\.001797324161494471\ \(0\)\
\-\ with\\:\\ 0\\.0005894416931480591\ \(0\)\
